These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3069209)

  • 41. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?
    Stys T; Lawson WE; Smaldone GC; Stys A
    Arch Intern Med; 2000 May; 160(10):1409-13. PubMed ID: 10826452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of angiotensin-converting enzyme inhibitors in heart failure].
    Dietz R; Osterziel KJ
    Z Kardiol; 1988; 77 Suppl 3():89-93. PubMed ID: 3062961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
    Bergler-Klein J; Sochor H; Pouleur H; Pacher R; Porenta G; Glogar D
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):194-8. PubMed ID: 7526050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal effects of angiotensin converting enzyme inhibitors in heart failure: a clinician's guide to minimizing azotemia and diuretic-induced electrolyte imbalances.
    Weinberg MS
    Clin Ther; 1993; 15(1):3-17; discussion 2. PubMed ID: 8458051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of cardiac failure with angiotensin-converting enzyme inhibitors and diuretics].
    Deray G; Martinez F; Jacobs C
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):735-40. PubMed ID: 8760660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ACE inhibitors for congestive heart failure.
    Med Lett Drugs Ther; 1988 Oct; 30(777):97-8. PubMed ID: 3173235
    [No Abstract]   [Full Text] [Related]  

  • 47. [Angiotensin-converting enzyme (ACE) inhibitors in cardiac decompensation; from randomized study to individual patient].
    van Vlies B
    Ned Tijdschr Geneeskd; 1992 Sep; 136(37):1796-8. PubMed ID: 1407135
    [No Abstract]   [Full Text] [Related]  

  • 48. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors].
    Kromer EP; Elsner D; Riegger GA
    Z Kardiol; 1991; 80 Suppl 2():11-5. PubMed ID: 2024538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure.
    Campbell DJ; Aggarwal A; Esler M; Kaye D
    Lancet; 2001 Nov; 358(9293):1609-10. PubMed ID: 11716889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of heart failure with angiotensin converting enzyme inhibitors].
    Svarstad E; Iversen BM
    Tidsskr Nor Laegeforen; 1990 Sep; 110(22):2896-9. PubMed ID: 2219071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Angiotensin converting enzyme inhibitors in the treatment of heart failure].
    Bettencourt P; Ferreira A
    Rev Port Cardiol; 2000 Dec; 19 Suppl 2():II51-6. PubMed ID: 11301911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
    Liebau G
    Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R
    Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.
    Gheorghiade M
    Can J Cardiol; 1990 Aug; 6 Suppl C():14C-17C. PubMed ID: 2205342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [ACE inhibitors in hypertension and heart failure].
    Riegger AJ
    Internist (Berl); 1992 Oct; 33(10):639-44. PubMed ID: 1428682
    [No Abstract]   [Full Text] [Related]  

  • 60. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.